What is the common examiner trap about Polity in UPSC exams?

The trap lies in mixing the dates and provisions: the CJM order was July 26, 2018, while the HC judgment was August 11, 2026. Also, don't conclude that 'Good Manufacturing Practices' clears the company — the inspection noted GMP, but the drug was still declared NSQ. Finally, 'Not of Standard Quality' under the Drugs Act is not the same as generic 'adulteration'.

What should UPSC aspirants remember about Polity for Prelims?

1. Target this Data: NSQ report dated August 31, 2016; CJM order July 26, 2018; HC order August 11, 2026. 2. Target this Article: Article 21 — right to life includes right to health. 3. Target this Act/Section: Sections 18(a)(i), 27(d), 34, Drugs and Cosmetics Act, 1940. 4. Target this Regulator: Central Drugs Standard Control Organisation (CDSCO).

PolitySocial Justice

Take AI Challenge ▸

News 18 of 28

J&K High Court: Safe Medicines Part of Article 21 Right to Life, Upholds Drug Prosecution

Q: Which constitutional provision did the Jammu and Kashmir and Ladakh High Court hold was implicated by the manufacture and distribution of sub-standard drugs?

Article 21 — Right to life and personal liberty, The High Court held that the right to life is not confined to physical existence but includes the right to live with dignity and encompasses health and well-being. It observed that sub-standard drugs directly implicate the constitutional concern underlying Article 21. Sections 34 and 27(d) are statutory provisions, not constitutional rights.

Q: Consider the following statements: 1. The High Court refused to cancel criminal proceedings against three directors of Corona Remedies Private Limited. 2. The High Court held that directors can never be prosecuted unless they personally handled the manufacturing process. 3. The High Court applied the principle of 'estoppel by conduct' because the company had earlier accepted the findings and sought a lenient view. Which of the statements given above is/are correct?

Both 1 and 3, Statement 1 is directly supported by the ruling refusing to quash the complaint. Statement 2 is incorrect because Section 34 creates liability for those 'in charge of and responsible' for the business, including consent, connivance or neglect, and the court held this is a question of evidence. Statement 3 is correct because the company's earlier reply accepted the findings and sought leniency, leading to estoppel by conduct.

Q: What was the date of the government analyst's report that declared the drug 'Not of Standard Quality'?

August 31, 2016, The government analyst at the Regional Drugs Testing Laboratory, Chandigarh, submitted the report on August 31, 2016. July 26, 2018 is the date on which the Chief Judicial Magistrate took cognisance; November 4, 2016 is the joint inspection date; September 22, 2016 is the date of the legal notice.

Q: What did the High Court say about the statutory safeguards in the Drugs and Cosmetics Act?

They serve not merely a regulatory purpose but also protect the health and life of drug consumers., The High Court observed that statutory safeguards in the Drugs and Cosmetics Act are an important legislative mechanism for protecting the health and life of those who consume such drugs. The GMP note during inspection did not stop the drug being declared NSQ, and the HC did not make GMP compliance a complete defence.

Polity Social IssuesSUPPORT

Target:UPSC GS-IIMPSCTeachingSSC GAPrelims HighMains HighStatic GK Link

13 Aug 2026

~2 min

Source: Indian Express

Key Data:Article 21Section 18(a)(i) read with Section 27(d), Drugs and Cosmetics Act, 1940Section 34, Drugs and Cosmetics Act, 1940August 31, 2016July 26, 2018August 11, 2026

Bodies:Jammu and Kashmir and Ladakh High CourtCentral Drugs Standard Control Organisation (CDSCO)Regional Drugs Testing Laboratory, ChandigarhChief Judicial Magistrate, JammuSupreme Court of India

Practice MCQs from today's news ▸

~2 min · Quick mode

What This Article Covers

1.J&K and Ladakh High Court held that right to health is part of the right to life and every medicine consumer is entitled to prescribed quality and safety standards.

2.The Court refused to quash proceedings against directors of Corona Remedies under Sections 18(a)(i) and 27(d) of the Drugs and Cosmetics Act, 1940, for the NSQ drug Locipil.

3.Directors' liability under Section 34 and procedural pleas like estoppel by conduct will be tested before the trial court; the High Court noted it was not deciding guilt or innocence.

The Big Picture

Prelims · HighMains · High

The J&K and Ladakh High Court has ruled that the right to health is part of the right to life under Article 21, making safe medicines a basic right, not just a consumer choice. It refused to quash criminal proceedings against directors of Corona Remedies for a 'Not of Standard Quality' drug, linking pharmaceutical regulation directly with constitutional protection of public health.

Exam Lens

Quick Exam Facts From News

Court & BenchJ&K and Ladakh High Court; Justice Wasim Sadiq Nargal

HC Order DateAugust 11, 2026

Drug Found NSQLocipil tablets (Sept 2015 batch, expiry May 2018)

Testing Lab & ReportRegional Drugs Testing Laboratory, Chandigarh; August 31, 2016

CJM Order Under ChallengeJuly 26, 2018, Chief Judicial Magistrate, Jammu

Legal ProvisionsSections 18(a)(i) read with 27(d) and Section 34, Drugs and Cosmetics Act, 1940; Article 21

ComplainantDrugs Inspector, Central Drugs Standard Control Organisation

CompanyCorona Remedies Private Limited, Ahmedabad

1-Minute Revision

›Court & Bench: J&K and Ladakh High Court; Justice Wasim Sadiq Nargal
›HC Order Date: August 11, 2026
›Target this Data: NSQ report dated August 31, 2016; CJM order July 26, 2018; HC order August 11, 2026.
›Target this Article: Article 21 — right to life includes right to health.
›Target this Act/Section: Sections 18(a)(i), 27(d), 34, Drugs and Cosmetics Act, 1940.
›Target this Regulator: Central Drugs Standard Control Organisation (CDSCO).

Mastered this topic? Test your knowledge with a full MCQ quiz.

Practice exam-style questions, track your score, and strengthen your recall.

News Snapshot

⚖️

Safe Medicines = Article 21 Right

The High Court ruled that the right to life includes health and well-being, so sub-standard drugs directly implicate constitutional protection.

💊

NSQ Drug Prosecution Upheld

A 2016 government analyst report declared Locipil tablets 'Not of Standard Quality', and the court refused to quash the magistrate's order against the pharma directors.

🏛️

Trial Court to Decide Liability

Whether directors were 'in charge of and responsible' for the company's business is a question of fact to be decided on evidence, not by quashing at the threshold.

Detailed Analysis & Strategic Depth

Context / Background

The case arose from a sample of Locipil tablets manufactured by Ahmedabad-based Corona Remedies Pvt Ltd in September 2015 with an expiry date of May 2018. A sample lifted from ESIC Model Hospital, Bari Brahmana, Jammu was tested at the Regional Drugs Testing Laboratory, Chandigarh, and declared 'Not of Standard Quality' on August 31, 2016. The Drugs Inspector, CDSCO, filed a complaint, and the Chief Judicial Magistrate, Jammu, took cognisance on July 26, 2018 under Section 18(a)(i) read with Section 27(d) of the Drugs and Cosmetics Act, 1940.

Core Analysis & Implications

Justice Wasim Sadiq Nargal held that Article 21 is not confined to physical existence but encompasses dignified living, including health and well-being. Since sub-standard drugs directly affect public health, their manufacture and distribution attracts constitutional scrutiny. The court rejected the directors' plea that they had no role, holding that liability under Section 34 is a question of fact to be established by evidence. The judgement also applied 'estoppel by conduct' because the company had earlier accepted the analyst's findings and sought leniency.

Judicial Precedents & Directors' Liability

The court relied on Supreme Court judgments in Dinesh B Patel v State of Gujarat and State of Kerala v M/s Panacea Biotec Ltd to observe that a technical approach should not be adopted in drug prosecutions. Whether directors were 'in charge of and responsible for' the conduct of business, or whether the offence was attributable to consent, connivance or neglect, must be decided on evidence. The High Court clarified it was not determining guilt or innocence and ordered the trial court to proceed independently.

Future Outlook / Way Forward

The trial court will now examine procedural objections, including alleged deficiencies under Sections 23 and 25 of the Act, and decide the matter on merits. The High Court found no patent illegality, jurisdictional error, perversity or abuse of process in the magistrate's order and vacated the interim stay granted on May 3, 2019. The ruling strengthens regulatory enforcement and signals that quashing petitions cannot be used to escape prosecution in public-health-related drug quality cases.

Key Facts at a Glance

Court & BenchJ&K and Ladakh High Court; Justice Wasim Sadiq Nargal

HC Order DateAugust 11, 2026

Drug Found NSQLocipil tablets (Sept 2015 batch, expiry May 2018)

Testing Lab & ReportRegional Drugs Testing Laboratory, Chandigarh; August 31, 2016

CJM Order Under ChallengeJuly 26, 2018, Chief Judicial Magistrate, Jammu

Legal ProvisionsSections 18(a)(i) read with 27(d) and Section 34, Drugs and Cosmetics Act, 1940; Article 21

ComplainantDrugs Inspector, Central Drugs Standard Control Organisation

CompanyCorona Remedies Private Limited, Ahmedabad

You've read the full analysis. Now test your understanding.

Practice exam-style questions based on this article.

Q1Static LinkageEasyUPSC, SSC, State PSC, Banking

Which constitutional provision did the Jammu and Kashmir and Ladakh High Court hold was implicated by the manufacture and distribution of sub-standard drugs?

Q2Statement-basedHardUPSC, SSC

Consider the following statements:

1. The High Court refused to cancel criminal proceedings against three directors of Corona Remedies Private Limited.

2. The High Court held that directors can never be prosecuted unless they personally handled the manufacturing process.

3. The High Court applied the principle of 'estoppel by conduct' because the company had earlier accepted the findings and sought a lenient view.

Which of the statements given above is/are correct?

Q3Data-centricMediumUPSC, SSC, Banking, State PSC

What was the date of the government analyst's report that declared the drug 'Not of Standard Quality'?

Q4Application/ImpactMediumUPSC, SSC, State PSC

What did the High Court say about the statutory safeguards in the Drugs and Cosmetics Act?

All 25 MCQs ▸

Read original article from Indian Express

You finished this topic

Practice 3 MCQs from this news Next Article

Explore Related Topics

PolityView Topic MCQs →Social IssuesView Topic MCQs →

PreviousTransparency in Healthcare: UK, Canada Models vs India's Regulatory Gaps for Exam Next Census 2027: First Digital Census with Caste Enumeration for All Communities; 40 Questions in PE Phase

Related Current Affairs

Polity Current Affairs

SC Directs Uniform Policy for Demolition & Rehabilitation of Unauthorised Homes Under Article 21

The Supreme Court has ruled that the state's power to demolish unauthorised constructions must be balanced with the duty to rehabilitate affected families, invoking Article 21 (right to dignity, shelter, livelihood). The court directed the Union and State governments to consider formulating a uniform demolition and rehabilitation policy.

Polity Current Affairs

Supreme Court Expands to 38 Judges: Diversity Deficit Exposed as Women Only 4.15%

Parliament passed the Supreme Court (Number of Judges) Amendment Bill, 2026, adding 4 judges to the apex court (strength now 38). However, the article underscores a glaring lack of diversity: women constitute only 4.15% of all SC judges ever appointed, and caste representation in High Courts remains abysmally low. For exam aspirants, this links directly to the collegium system, judicial appointments, social justice, and pendency crisis.

Polity Current Affairs

SC Upholds EC's SIR, Citizenship Under MHA; 13 Crore Deletions, Aadhaar Alternative Proposed

The Supreme Court upheld the EC's Special Intensive Revision (SIR) of electoral rolls, which deleted over 13 crore names, but clarified that citizenship determination is solely under the Ministry of Home Affairs. This raises critical debates on voter rights, due process, and the viability of Aadhaar-based verification as a cost-effective, inclusive alternative to house-to-house surveys.

Polity Current Affairs

Supreme Court Rules 1978 'Industry' Definition Not Binding on Industrial Relations Code, 2020

The Supreme Court's nine-judge Constitution Bench ruled that the 1978 landmark precedent defining 'industry' will not automatically apply to the new Industrial Relations Code, 2020. This severs the worker-friendly expansive interpretation, creating a clean slate for future labour disputes under the new code.

Polity Current Affairs

SC Proposes Exempting Current Class 6 from Three-Language Policy; Centre Seeks More Time

The Supreme Court has proposed exempting the current Class 6 batch from the mandatory three-language policy, suggesting implementation from January 1, 2027. The Centre has sought more time to decide, while the court has asked for details on teacher availability and infrastructure.

Polity Current Affairs

SC's 76-Year Journey: Reforms at Magistracy Level Needed for Judicial Overhaul

A former Delhi High Court judge critiques the Indian judiciary's performance over 76 years, highlighting issues like eviction of poor without rehabilitation, failure to curb extra-legal punishments, and delay in upholding progressive judgments. The article argues that meaningful judicial reform must begin at the magisterial level, focusing on mentoring, mental health support, and performance evaluation reforms.

Polity Current Affairs

Supreme Court Takes Suo Motu Cognisance of Delhi-NCR Sexual Assaults, Cites Article 21 and Nirbhaya Parallel

The Supreme Court has taken suo motu cognisance of recent sexual assault cases in Delhi-NCR, flagging lax patrolling and administrative failures that make public spaces 'zones of high risk'. The court invoked Article 21 (right to life and personal liberty) and drew a painful parallel to the 2012 Nirbhaya case, demanding accountability and a measurable response from authorities. This has major implications for law enforcement accountability, women's safety, and judicial oversight.

Polity Current Affairs

SC Seeks Replies on NRC ID Cards: 3.11 Crore Await Documents, 19 Lakh Excluded

The Supreme Court has directed the Centre and Assam government to respond to pleas seeking issuance of identity cards to 3.11 crore people included in the National Register of Citizens (NRC) 2019, while another 19 lakh excluded persons await the appeal process. This case is critical for exam aspirants as it tests knowledge of the Citizenship Act, NRC process, and Assam Accord provisions.

Start Today's Quiz(25 Qs)

Take Today's Quiz

25 Qs • 5-7 Mins

J&K High Court: Safe Medicines Part of Article 21 Right to Life, Upholds Drug Prosecution

Exam Lens

Quick Exam Facts From News

1-Minute Revision

News Snapshot

Safe Medicines = Article 21 Right

NSQ Drug Prosecution Upheld

Trial Court to Decide Liability

Detailed Analysis & Strategic Depth

Context / Background

Core Analysis & Implications

Judicial Precedents & Directors' Liability

Future Outlook / Way Forward

Prelims Flashpoints

Key Facts at a Glance